Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 74.30 +0.96%   SPY: 166.94 +0.97%
Quote Spy OSIR NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.


Osiris Therapeutics (OSIR)

@ May-17
Click the portfolio to add OSIR:
Close [X]
+ Add OSIR to Portfolio
  
  Last Trade: $11.27 +0.67 (6.32%)
  Volume: 175,051 163% of avg daily volume
       
  Avg Volume: 107,423
3-Month Chart (Larger chart w/volume)
Close [X]
1m  3m  6m  1y  2y
  Day's Range: 10.42 - 11.39
  Open: 10.60
  Previous Close: 10.60
  52-wk Range: 4.93 - 14.46
  Market Cap: 371.1M
  P/E: -27.7
  Div Yield: $0.00 (0.00%)
Indexes
Biotechnology Stocks (+0.7%)
Stem Cell Stocks (+0.5%)
Spy OSIR

? Pro holders
? Member holders
? Items submitted
Additional OSIR resources



Customize Links
To see which Pros and tickerspy members own OSIR Sign up now
Latest OSIR Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

Osiris Therapeutics Announces First Quarter 2013 Financial Results
OSIR  
Linked by BusinessWire - May 07, 08:00AM from (www.businesswire.com)
Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading stem cell company focused on developing and marketing products to treat  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Osiris Therapeutics Announces First Quarter 2013 Financial Results Conference Call
OSIR  
Linked by BusinessWire - April 25, 05:00PM from (www.businesswire.com)
Osiris Therapeutics, Inc. (NASDAQ: OSIR) today announced that it will report its financial results for the first quarter  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Market Close: Today’s Big Winners & Losers
RWC  ACUR  MELA  OPXA  END  PTEK  APP  OSIR  HCI  RDIB  
Linked by 24/7 Wall St. - March 06, 04:25PM from (247wallst.com)
Here are today’s five biggest gaining stocks at closing: Osiris Therapeutics Inc.. (NASDAQ: OSIR) is up 35.2% at $9.34.  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Market Wrap for Wednesday, March 6: Stocks Close Mixed as Euro Tests Key Support Level Ahead of ECB Meeting
SPLS  SPY  VNO  AEO  TIBX  SOHU  JCP  PAY  OSIR  AVAV  UUP  HCI  TFM  TLT  
Linked by Benzinga.com - March 06, 04:09PM from (www.benzinga.com)
The U.S. stock market closed mixed on Wednesday, with the Dow extending gains into record territory while the Nasdaq retreated slightly.
 more ...

Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Osiris Therapeutics Reports Fourth Quarter and Full Year 2012 Financial Results
OSIR  
Linked by BusinessWire - March 06, 08:00AM from (www.businesswire.com)
Osiris Therapeutics, Inc. (NASDAQ: OSIR) the leading stem cell company focused on developing and marketing products to treat  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Osiris Therapeutics Establishes Direct Sales Force for Grafix®
OSIR  
Linked by BusinessWire - March 01, 07:30AM from (www.businesswire.com)
Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading company focused on developing and marketing stem cell products to treat  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Osiris Therapeutics Announces Fourth Quarter and Full Year 2012 Financial Results Conference Call
OSIR  
Linked by BusinessWire - February 22, 05:00PM from (www.businesswire.com)
Osiris Therapeutics, Inc. (NASDAQ: OSIR) today announced that it will report its financial results for the fourth quarter  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Osiris Therapeutics Regains Worldwide Rights to Prochymal and Chondrogen
OSIR  
Linked by BusinessWire - September 28, 12:00AM from (www.businesswire.com)
Osiris Therapeutics, Inc. (NASDAQ: OSIR) today announced the conclusion of its collaboration with Genzyme, a Sanofi company.  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Tough Earnings May Be Ahead
CPB  ETN  LOW  KKD  [CBE]  HOKU  OSIR  FB  
Linked by tickerspy Newswire - May 21, 04:38PM from (www.tickerspy.com)
After over two weeks of selling pressure, stocks bounced, helped by pro-growth comments from Chinese Premier Wen Jiabao.  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
A Stem-Cell-Based Drug Gets Approval in Canada
OSIR  
Linked by NYTimes - May 17, 09:47PM from (feeds.nytimes.com)
Prochymal, developed by Osiris Therapeutics, is a preparation of mesenchymal stem cells, which are obtained from the bone  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7 8 9 10



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource